“…Contributing to its lack of recognition, oral LPP is likely frequently underdiagnosed due to the lack of prescribed immunofluorescence studies in cases that may appear similar to oral LP. Including the recently published findings of Fukuda and colleagues, there are now 35 reported cases of LPP with well‐characterized oral involvement that have undergone confirmatory testing with direct immunofluorescence, 31 (89%) of which presented clinically with classic reticular or erosive LP with an absence of intraoral bullae . While we recognize that oral lesions of both diseases are treated in a similar manner, the utility of immunofluorescence studies in establishing the diagnosis of oral LPP is of importance, as LPP is considered a systemic autoimmune disease within the pemphigoid family that may present with a scarring phenotype affecting the conjunctivae, larynx, and/or esophagus, which carries a risk of progression to complications such as blindness, respiratory distress, and dysphagia, respectively …”